Table 2 Blood transfusion, hemorrhage control requirements, and outcomes
Variable | Non-geriatric age group (n = 12,241) | Geriatric age group (n = 1653) | p-value |
|---|---|---|---|
Blood transfusion, units | Â | Â | Â |
 Within 4 h |  |  |  |
  RBC, median (IQR) | 9 (6–14) | 8 (6–13) |  < 0.001 |
  Plasma, median (IQR) | 6 (3–9) | 4 (3–9) |  < 0.001 |
  Platelets, median (IQR) | 1 (0–2) | 1 (0–2) | 0.024 |
 Within 24 h |  |  |  |
  RBC, median (IQR) | 11 (7–16) | 10 (7–16) | 0.188 |
  Plasma, median (IQR) | 7 (4–12) | 6 (4–11) | 0.001 |
  Platelets, median (IQR) | 2 (1–3) | 2 (1–3) | 0.074 |
Hemorrhage control | Â | Â | Â |
 Angioembolization, n (%) | 1713 (13.9) | 337 (20.4) |  < 0.001 |
 Surgery, n (%) | 9743 (79.6) | 1128 (68.2) |  < 0.001 |
Outcome | Â | Â | Â |
 In-hospital mortality, n (%) | 3464 (28.3) | 782 (47.3) |  < 0.001 |
 24-h mortality, n (%) | 2231 (18.2) | 430 (26.0) |  < 0.001 |
 Hospital LOS, median (IQR) | 14 (3–27) | 9 (1–22) |  < 0.001 |
 ICU admission, n (%) | 10,641 (86.9) | 1444 (87.3) | 0.668 |
 ICU LOS, median (IQR) | 8 (2–12) | 7 (2–16) | 0.157 |
 Ventilator days, median (IQR) | 4 (2–12) | 4 (1–12) | 0.443 |
 Any adverse events, n (%) | 2685 (21.9) | 377 (22.8) | 0.440 |
  Cardiac failure, n (%) | 43 (0.4) | 44 (2.7) |  < 0.001 |
  Respiratory failure, n (%) | 698 (5.7) | 82 (5.0) | 0.241 |
  Renal failure, n (%) | 856 (7.0) | 136 (8.2) | 0.075 |
  Thrombosis, n (%) | 1337 (11.0) | 134 (12.2) | 0.102 |
  Sepsis, n (%) | 370 (3.0) | 37 (3.0) | 1.000 |
  Others, n (%) | 1052 (8.6) | 149 (9.0) | 0.412 |